These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10653646)

  • 1. Regulation of plasmin activity by annexin II tetramer.
    Fitzpatrick SL; Kassam G; Choi KS; Kang HM; Fogg DK; Waisman DM
    Biochemistry; 2000 Feb; 39(5):1021-8. PubMed ID: 10653646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of annexin II tetramer in the activation of plasminogen.
    Kassam G; Choi KS; Ghuman J; Kang HM; Fitzpatrick SL; Zackson T; Zackson S; Toba M; Shinomiya A; Waisman DM
    J Biol Chem; 1998 Feb; 273(8):4790-9. PubMed ID: 9468544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of annexin II tetramer in plasminogen activation.
    Kang HM; Choi KS; Kassam G; Fitzpatrick SL; Kwon M; Waisman DM
    Trends Cardiovasc Med; 1999; 9(3-4):92-102. PubMed ID: 10578524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin II tetramer inhibits plasmin-dependent fibrinolysis.
    Choi KS; Ghuman J; Kassam G; Kang HM; Fitzpatrick SL; Waisman DM
    Biochemistry; 1998 Jan; 37(2):648-55. PubMed ID: 9425087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
    MacLeod TJ; Kwon M; Filipenko NR; Waisman DM
    J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.
    Kassam G; Le BH; Choi KS; Kang HM; Fitzpatrick SL; Louie P; Waisman DM
    Biochemistry; 1998 Dec; 37(48):16958-66. PubMed ID: 9836589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
    Kwon M; MacLeod TJ; Zhang Y; Waisman DM
    Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
    Lobov S; Croucher DR; Saunders DN; Ranson M
    Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of plasmin-dependent fibrin clot lysis by annexin II heterotetramer.
    Choi KS; Fitzpatrick SL; Filipenko NR; Fogg DK; Kassam G; Magliocco AM; Waisman DM
    J Biol Chem; 2001 Jul; 276(27):25212-21. PubMed ID: 11319229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin.
    Kwon M; Yoon CS; Jeong W; Rhee SG; Waisman DM
    J Biol Chem; 2005 Jun; 280(25):23584-92. PubMed ID: 15849182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin II: a mediator of the plasmin/plasminogen activator system.
    Hajjar KA; Krishnan S
    Trends Cardiovasc Med; 1999 Jul; 9(5):128-38. PubMed ID: 10639727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p11 subunit of annexin II heterotetramer is regulated by basic carboxypeptidase.
    Fogg DK; Bridges DE; Cheung KK; Kassam G; Filipenko NR; Choi KS; Fitzpatrick SL; Nesheim M; Waisman DM
    Biochemistry; 2002 Apr; 41(15):4953-61. PubMed ID: 11939791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression.
    Mai J; Waisman DM; Sloane BF
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):215-30. PubMed ID: 10708859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the annexin A2 heterotetramer in vascular fibrinolysis.
    Madureira PA; Surette AP; Phipps KD; Taboski MA; Miller VA; Waisman DM
    Blood; 2011 Nov; 118(18):4789-97. PubMed ID: 21908427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of annexin II heterotetramer as a plasmin reductase.
    Kwon M; Caplan JF; Filipenko NR; Choi KS; Fitzpatrick SL; Zhang L; Waisman DM
    J Biol Chem; 2002 Mar; 277(13):10903-11. PubMed ID: 11781322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen-stimulated airway smooth muscle cell proliferation is mediated by urokinase and annexin A2, involving plasmin-activated cell signalling.
    Stewart AG; Xia YC; Harris T; Royce S; Hamilton JA; Schuliga M
    Br J Pharmacol; 2013 Dec; 170(7):1421-35. PubMed ID: 24111848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
    Sharma MC; Sharma M
    Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
    Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
    J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. tPA receptors and the fibrinolytic response in multiple sclerosis lesions.
    Gveric D; Herrera BM; Cuzner ML
    Am J Pathol; 2005 Apr; 166(4):1143-51. PubMed ID: 15793294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.